JP6279590B2 - 酸性条件でアナライトを測定するための方法およびキット - Google Patents

酸性条件でアナライトを測定するための方法およびキット Download PDF

Info

Publication number
JP6279590B2
JP6279590B2 JP2015535610A JP2015535610A JP6279590B2 JP 6279590 B2 JP6279590 B2 JP 6279590B2 JP 2015535610 A JP2015535610 A JP 2015535610A JP 2015535610 A JP2015535610 A JP 2015535610A JP 6279590 B2 JP6279590 B2 JP 6279590B2
Authority
JP
Japan
Prior art keywords
analyte
acidic
protein
ligand
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015535610A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015531487A (ja
JP2015531487A5 (enExample
Inventor
マッツ・インガネス
ピルヨ・レートネン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyros Patent AB
Original Assignee
Gyros Patent AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyros Patent AB filed Critical Gyros Patent AB
Publication of JP2015531487A publication Critical patent/JP2015531487A/ja
Publication of JP2015531487A5 publication Critical patent/JP2015531487A5/ja
Application granted granted Critical
Publication of JP6279590B2 publication Critical patent/JP6279590B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
JP2015535610A 2012-10-03 2013-10-03 酸性条件でアナライトを測定するための方法およびキット Active JP6279590B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1251116-8 2012-10-03
SE1251116 2012-10-03
SE1350373-5 2013-03-25
SE1350373 2013-03-25
PCT/SE2013/051161 WO2014055025A1 (en) 2012-10-03 2013-10-03 Method and kit for analyte determination at acidic conditions

Publications (3)

Publication Number Publication Date
JP2015531487A JP2015531487A (ja) 2015-11-02
JP2015531487A5 JP2015531487A5 (enExample) 2016-10-20
JP6279590B2 true JP6279590B2 (ja) 2018-02-14

Family

ID=50435248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015535610A Active JP6279590B2 (ja) 2012-10-03 2013-10-03 酸性条件でアナライトを測定するための方法およびキット

Country Status (5)

Country Link
US (1) US10036745B2 (enExample)
EP (1) EP2904393B1 (enExample)
JP (1) JP6279590B2 (enExample)
CN (1) CN104718453B (enExample)
WO (1) WO2014055025A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118443922A (zh) * 2016-09-06 2024-08-06 富士瑞必欧株式会社 肿瘤标记物的测定方法及测定试剂
CN109477832A (zh) * 2016-09-06 2019-03-15 富士瑞必欧株式会社 甲状腺球蛋白的测定方法及测定试剂
JP6999561B2 (ja) * 2016-09-13 2022-02-10 富士レビオ株式会社 心筋トロポニンの測定方法及び測定試薬
PL3717916T3 (pl) * 2017-11-29 2025-04-07 F. Hoffmann-La Roche Ag Test do oznaczania przeciwciał przeciwlekowych z tłumieniem oddziaływania z cząsteczką docelową
ES3038185T3 (en) * 2018-08-03 2025-10-10 Bristol Myers Squibb Co Methods for detecting anti-drug antibodies
CN113960318A (zh) * 2021-09-28 2022-01-21 苏州赛分科技股份有限公司 一种基于酶联免疫的重组蛋白a测定方法及试剂盒
KR20250037485A (ko) * 2022-07-13 2025-03-17 리제너론 파마슈티칼스 인코포레이티드 분석물 검출을 위한 약산 면역분석법

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE448190B (sv) 1985-06-03 1987-01-26 Pharmacia Ab Sett att bestemma fc-dels-bindande bakteriella polypeptider
US4703001A (en) * 1985-10-23 1987-10-27 Synbiotics, Corporation Immunoassay for the detection of serum analytes using pH dependent chastropic acids
WO1991010911A1 (en) 1990-01-19 1991-07-25 Repligen Corporation Immunoassay of protein a under acidic conditions
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
GB9809943D0 (en) 1998-05-08 1998-07-08 Amersham Pharm Biotech Ab Microfluidic device
AU2002243148A1 (en) 2001-03-19 2002-10-03 Gyros Ab Structural units that define fluidic functions
WO2002075312A1 (en) 2001-03-19 2002-09-26 Gyros Ab Characterization of reaction variables
WO2003018198A1 (en) 2001-08-28 2003-03-06 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
WO2003076568A2 (en) * 2002-02-11 2003-09-18 Alexion Pharmaceuticals, Inc. Immunotherapeutics for biodefense
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
JP4115728B2 (ja) 2002-03-26 2008-07-09 デンカ生研株式会社 フロースルー式検査法用組成物、これを用いたキット及び検査法
JP4423189B2 (ja) * 2002-05-31 2010-03-03 ユィロス・パテント・アクチボラグ 表面プラズモン共鳴に基づく検出装置
SE0300822D0 (sv) 2003-03-23 2003-03-23 Gyros Ab A collection of Micro Scale Devices
EP1608587B1 (en) 2003-03-23 2016-11-23 Gyros Patent Ab Preloaded microscale devices
CN101097217A (zh) * 2006-06-29 2008-01-02 王珊珊 一种提高血清特异性生长因子免疫学测定灵敏度的技术
EP2062052A4 (en) 2006-09-14 2010-02-03 Ge Healthcare Bio Sciences Ab METHOD FOR DETERMINING ANALYZ CONCENTRATION
CN101583872A (zh) * 2006-09-14 2009-11-18 通用电气健康护理生物科学股份公司 测定待分析物浓度的方法
WO2008043075A2 (en) * 2006-10-05 2008-04-10 Wyeth Compositions for the treatment of scleritis
WO2009022001A1 (en) * 2007-08-16 2009-02-19 Novartis Ag Improvement of drug tolerance in immunogenicity testing
CN101965516A (zh) 2008-04-03 2011-02-02 弗·哈夫曼-拉罗切有限公司 聚乙二醇化胰岛素样生长因子测定
JP5710482B2 (ja) 2008-09-11 2015-04-30 アンスティテュ・パストゥール Ｈｍｇｂ１依存型誘発のｈｉｖ−１複製および持続の調節によるヒト免疫不全ウイルス感染の監視および阻害
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
ES2530175T3 (es) * 2011-02-17 2015-02-26 Nestec S.A. Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF
KR102076354B1 (ko) * 2012-02-15 2020-02-10 바이오콘 리미티드 분석물의 검출 및 선택적인 정량화를 위한 공정

Also Published As

Publication number Publication date
WO2014055025A1 (en) 2014-04-10
JP2015531487A (ja) 2015-11-02
CN104718453B (zh) 2017-03-08
EP2904393A1 (en) 2015-08-12
EP2904393B1 (en) 2018-11-28
US10036745B2 (en) 2018-07-31
CN104718453A (zh) 2015-06-17
EP2904393A4 (en) 2016-05-04
US20150268238A1 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
JP6279590B2 (ja) 酸性条件でアナライトを測定するための方法およびキット
Zhang et al. High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents
CN112105640B (zh) 检测神经退行性变的测定
US20240280591A1 (en) Blood-based assay for detecting tauopathy or amyloidogenic disease
JP7382071B2 (ja) 糖化ヘモグロビン（％）の測定方法
EP3243078A1 (en) A universal assay for determining the quantity of tnf inhibitory drugs and their corresponding anti-drug-antibodies
CN109891240A (zh) 载脂蛋白e4的检测方法
US20240410881A1 (en) Methods and systems for detecting antibodies by surface plasmon resonance
WO2022076459A1 (en) High-throughput method for lp(a)-cholesterol quantitation
JP6170644B1 (ja) 抗医薬品抗体の測定方法
JP2005524087A (ja) サンドイッチアッセイおよびキット
JP5231954B2 (ja) アルブミン測定試薬
Pihlblad Development and comparison of bioanalytical methods to measure free analyte
Giannoglou Investigating CIC-C1q ELISA for measuring in vitro activation of the complement system on intravenous immunoglobulin
JP4753366B2 (ja) ％ｃｄｔの定量方法
KR20250003814A (ko) 보체 의존성 세포독성 방법
WO2017033846A1 (ja) 免疫試験方法および免疫試験キット
JP2004132816A (ja) 酵素免疫測定法による抗血液凝固因子抗体の定量方法
WO2006132809A2 (en) Monoclonal antibody reagents
JPH0322945B2 (enExample)
JP2009142269A (ja) ヒトＩｇＧのＦｃを含有するタンパク質の測定試薬
JP2017502285A (ja) 抗体の分析
HK40043196A (en) Assays to detect neurodegeneration
Kärnhall New SPR based assays for plasma protein titer determination
Engqvist A generic capture assay for immunogenicity, using Biacore

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150715

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160902

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160902

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170627

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170901

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180109

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180117

R150 Certificate of patent or registration of utility model

Ref document number: 6279590

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250